Healthcare Services

Atrial Fibrillation Market Future Outlook Showing Expansion Toward $27.87 Billion by 2030

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Atrial Fibrillation Market Over The Period 2026–2030?

The atrial fibrillation market size has observed rapid growth in recent years. It is projected to expand from $15.1 billion in 2025 to $17.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.2%. The expansion seen in the historic period can be ascribed to the increasing prevalence of atrial fibrillation in aging populations, improved access to cardiac diagnostic technologies, wider availability of anticoagulant therapies, the expansion of electrophysiology labs, and growing awareness of stroke prevention.

The atrial fibrillation market size is projected to experience significant expansion in the coming years. It is anticipated to reach $27.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period can be attributed to several factors, including a heightened demand for personalized arrhythmia treatments, the increasing uptake of wearable cardiac monitoring devices, the broadening of hybrid treatment methods, increased investments in electrophysiology infrastructure, and a greater emphasis on long-term rhythm management outcomes. Key trends expected in the same period involve a greater acceptance of catheter ablation procedures, the expanding utilization of advanced cardiac mapping systems, a surging preference for minimally invasive treatments, the enlargement of pharmacological rhythm control therapies, and an intensified focus on early diagnosis and monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Which Major Factors Are Driving The Expansion Of The Atrial Fibrillation Market?

The growing prevalence of cardiovascular diseases is projected to propel the atrial fibrillation market. These disorders, which affect the heart and blood vessels and include conditions like coronary artery disease, heart failure, and arrhythmias, present considerable risks to cardiovascular health. The rising incidence of such conditions highlights an increasing need for advanced diagnostic and therapeutic interventions, thereby advancing the atrial fibrillation market as healthcare systems address these escalating challenges. For example, in October 2024, the CDC (Centers for Disease Control and Prevention), a U.S-based government agency, reported that 919,032 individuals died from cardiovascular disease in 2023, representing 1 in every 3 deaths. Additionally, approximately 805,000 people in the United States experience a heart attack annually. Consequently, the substantial global burden of cardiovascular diseases is set to drive the atrial fibrillation market.

How Is The Atrial Fibrillation Market Divided Into Its Major Segments?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures

What Industry Trends Are Redefining The Atrial Fibrillation Market?

Leading companies in the atrial fibrillation market are launching innovative products and solutions, such as patient-centric clinical decision support tools, to bolster their market position. Clinical decision support tools (CDSTs) are software or electronic systems engineered to assist healthcare professionals in making informed and timely decisions regarding patient care. These tools are developed to integrate relevant clinical information from various sources. For example, in August 2023, GE HealthCare, a US-based multinational medical technology company, introduced CardioVisio, a patient-centered clinical decision support tool designed to help doctors apply evidence-based clinical decision support guided by current atrial fibrillation guidelines and visualize longitudinal data from diverse sources relevant for illness progression. CardioVisio for atrial fibrillation can aid cardiologists by streamlining clinical image interpretation and providing a view of the patient’s heart history, as well as their entire healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.

Who Are The Prominent Organizations Shaping The Atrial Fibrillation Market?

Major companies operating in the atrial fibrillation market are AtriCure Inc, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Sanofi SA, Bayer AG, Pfizer Inc, Daiichi Sankyo Company Limited, AstraZeneca PLC, Biotronik SE & Co KG, Kardium Inc, Acutus Medical Inc, Apama Medical Inc, CardioFocus Inc, AliveCor Inc, iRhythm Technologies Inc, BioSig Technologies Inc

Read the full atrial fibrillation market report here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Region Currently Holds The Largest Share Of The Atrial Fibrillation Market?

North America was the largest region in the atrial fibrillation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Atrial Fibrillation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2026, By The Business Research Company

Wearable Heart Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Arrhythmia Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795